Torsten Unge

Structure and functionality in flavivirus NS-proteins: Perspectives for drug design

David I. Stuart, Rolf Hilgenfeld, Raymond J. Owens, 2010, Antiviral research.

Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.

Martin Lindh, Anders Karlén, Mats Larhed, 2011, Journal of medicinal chemistry.

Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors.

Wesley Schaal, Anders Karlén, Magnus Björsne, 2003, European journal of biochemistry.

Interaction kinetic characterization of HIV-1 reverse transcriptase non-nucleoside inhibitor resistance.

U Helena Danielson, M. Geitmann, T. Unge, 2006, Journal of medicinal chemistry.

Biosensor-based kinetic characterization of the interaction between HIV-1 reverse transcriptase and non-nucleoside inhibitors.

U Helena Danielson, M. Geitmann, T. Unge, 2006, Journal of medicinal chemistry.

Structures of Mycobacterium tuberculosis 1-Deoxy-D-xylulose-5-phosphate Reductoisomerase Provide New Insights into Catalysis*

Jens Carlsson, T. A. Jones, T Alwyn Jones, 2007, Journal of Biological Chemistry.

Symmetric fluoro-substituted diol-based HIV protease inhibitors. Ortho-fluorinated and meta-fluorinated P1/P1'-benzyloxy side groups significantly improve the antiviral activity and preserve binding efficacy.

Anders Hallberg, Guido Zuccarello, L. Vrang, 2004, European journal of biochemistry.

The 1.9 A resolution structure of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase, a potential drug target.

Torsten Unge, Lena M Henriksson, Christofer Björkelid, 2006, Acta crystallographica. Section D, Biological crystallography.

The three-dimensional structure of the bacterial virus MS2

Lars Liljas, L. Liljas, T. Unge, 1990, Nature.